Rather than picking targets based on conventional approaches, Immunome is letting a patient‘s ability to fight the disease guide target selection and therapy identification.
Driving Drug Discovery Using Patients’ Immune Response
By Michael Tattory|
2019-12-09T15:35:42-04:00
December 6th, 2019|News|Comments Off on Driving Drug Discovery Using Patients’ Immune Response